Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model
Xiaonan Zhang(Shanghai Public Health Clinical Center), Zhenghong Yuan(Shanghai Medical College of Fudan University), Xiaoling Zhang(Chinese Academy of Sciences), Zhigang Song(Fudan University), Yunwen Hu(Southern University of Science and Technology), Lixiang Chen(Shanghai Public Health Clinical Center), Boyin Qin(Shanghai Public Health Clinical Center)
Cited by 98
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
|The Lancet|2013|359
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
|Nature Communications|2021|299